Body Fat as a Biomarker? Study of ADC Use in DLBCL Suggests “Yes”
AJMC,
Mary Caffrey Investigators are increasingly looking to biomarkers to predict cancer progression and response to treatment.
Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial
Overview of attention for article published in JCO Clinical Cancer Informatics, July 2025
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (90th percentile)
Readers on
- mendeley
- 1 Mendeley